Skip to content
Home » Oncology » Oncology – UTUC » Surveillance after UTUC treatment

Surveillance after UTUC treatment

Rationale for surveillance:

  • Detect bladder tumours
  • Detect local recurrence or distant metastases
  • Detect recurrences in contra-lateral upper tract, or ipsilateral upper tract if following after kidney sparing surgery

 

EAU guidelines after nephroureterectomy

Low risk

  • Cystoscopy at 3 months, then 9 months later, than annually for 5 years
  • No comment on cytology or imaging

High risk

  • Cystoscopy and cytology every 3 months for 2 years, then 6 monthly until 5 years, then annually
  • CT IVP + CT chest every 6 months for 2 years, then annually

 

EAU guidelines after kidney sparing surgery

Low risk

  • Ureteroscopy at 3 months
  • Cystoscopy and CT IVP at 3 months, 6 months, then annually for 5 years

High risk

  • Cystoscopy, cytology, CT IVP and CT chest at 3 months, 6 months, then annually.
  • Ureteroscopy with washings at 3 months and 6 months.

 

In real life

Bespoke management per patient based on risk of recurrence, GA risks and frailty, renal function and resources available.

After neph-u:

  • Cystoscopy and cytology at 3 months, then 6 monthly. CT IVP/chest at 6 months.

After endoscopic management:

  • Early re-look cystoscopy/ureteroscopy/RPGs at 3 month intervals, CT IVP at 6 months, stretch out cystoscopy/ureteroscopy based on risk and recurrences